Home › Alzheimer's Disease › Florida › Ocala
Alzheimer's Disease clinical trials in Ocala, FL
6 studies for Alzheimer's Disease are looking for participants at sites in and around Ocala (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- Renstar Medical Research, Ocala
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
RecruitingPhase 3
- Renstar Medical Research, Ocala
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
RecruitingPhase 3
- Local Institution - 1608, Ocala
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
RecruitingPhase 2
- Renstar Medical Research ( Site 1012), Ocala
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
RecruitingPhase 3
- Renstar Medical Research, Ocala
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
RecruitingPhase 2
- Renstar Medical Research, Ocala
About Alzheimer's Disease
Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.
More about Alzheimer's Disease on MedlinePlus
Alzheimer's Disease trials in other cities
- Boston, MA26 studies
- Orlando, FL25 studies
- St. Louis, MO22 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Tampa, FL17 studies
- Atlanta, GA16 studies
- Philadelphia, PA15 studies
- Phoenix, AZ15 studies
- The Villages, FL15 studies
- Los Angeles, CA14 studies
- Indianapolis, IN14 studies
Other studies in Ocala
- Non-Small Cell Lung Cancer10 studies
- Steatotic Liver Disease8 studies
- Obesity7 studies
- Overweight6 studies
- COPD5 studies
- Heart Failure5 studies
- Mild Cognitive Impairment3 studies
- Metastatic Cancer3 studies
- Atherosclerosis3 studies
- Cardiovascular Disease3 studies
- Chronic Pain3 studies
- Liver Diseases3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.